Join to view full profile
200 W Arbor DrSan Diego, CA 92103
Phone+1 858-657-6110
Fax+1 619-543-3183
Dr. Terkeltaub is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Scripps Clinic/Scripps Green HospitalFellowship, Allergy and Immunology, 1981 - 1984
McGill University Faculty of MedicineClass of 1976
Certifications & Licensure
CA State Medical License 1982 - 2028
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate c...Georgios Filippou, Laura Pezzoni, Emilio Filippucci, Sara K Tedeschi, Tristan Pascart
Annals of the Rheumatic Diseases. 2026-11-01 - The association of CT-detected intra-articular calcification with MRI-detected effusion-synovitis and Hoffa-synovitis in knee OA: The Multicenter Osteoarthritis study.Jean W Liew, Mohamed Jarraya, Ali Guermazi, Nene C Ukonu, Gabriela Rabasa
Osteoarthritis and Cartilage. 2026-08-01 - 1 citationsA Metabolomic Signature Predicts Gout Flare Clinical Outcome Associated With Colchicine Prophylaxis.Wenyan Sun, Lingfang Xu, Haibing Chen, Mingshu Sun, Zhiqiang Li
Arthritis & Rheumatology. 2026-08-01
Journal Articles
- Authors’ Reply to Letter to the EditorTuhina Neogi, Robert Terkeltaub, Arthritis & Rheumatology
- Arhalofenate Acid Inhibits Monosodium Urate Crystal-Induced Inflammatory Responses Through Activation of AMP-Activated Protein Kinase (AMPK) SignalingRobert Terkeltaub, MD, BioMed Central
- Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES) Trial and Associated FDA Public Sa...Robert Terkeltaub, Tuhina Neogi, Arthritis & Rheumatology
Press Mentions
IL-6 Receptor Inhibitors Show Early Promise for CPPDDecember 20th, 2024- New Look at an Ancient Disease: Study Finds Novel Treatment Targets for GoutDecember 13th, 2022
Q&A: Treatments for GoutApril 18th, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: